Literature DB >> 10523570

Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay.

S Pongsunk1, N Thirawattanasuk, N Piyasangthong, P Ekpo.   

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis. In northeast Thailand, this gram-negative bacterium is a major cause of mortality from septicemia. The definitive diagnosis of this disease is made by bacterial culture. In this study, we produced a monoclonal antibody (MAb) specific to the 30-kDa protein of B. pseudomallei by in vivo and in vitro immunization of BALB/c mice with a crude culture filtrate antigen. The MAb could directly agglutinate with all 243 clinical isolates of B. pseudomallei but not with other gram-negative bacteria, except for one strain of Burkholderia mallei. However, the MAb cross-reacted with the gram-positive Bacillus sp. and Streptococcus pyogenes. B. pseudomallei in brain heart infusion broth (BHIB) subcultured from a BacT/Alert automated blood culture system could be identified by simple agglutination with this MAb assay. The sensitivity and specificity of direct agglutination compared to the "gold standard," the culture method, were 94.12 and 98.25%, respectively. However, the MAb adsorbed to polystyrene beads or latex particles directly identified the bacterium in blood culture specimens and in BHIB subcultured from a BacT/Alert automated blood culture system. The sensitivity of the latex agglutination test was 100% for both blood culture and BHIB specimens. The specificity was 85.96 and 96.49% for the blood culture and BHIB specimens, respectively. The specificity could be increased if the nonspecific materials in the blood culture broths were eradicated by centrifugation at low speeds. Thus, a combination of blood culture and the agglutination method could be used for the rapid diagnosis of melioidosis in the routine bacteriological laboratory. This method could speed up detection of the bacterium in blood culture by at least 2 days, compared to the conventional bacterial culture method. In addition, the MAb is stable at room temperature for 2 weeks and at 4, -20, and -70 degrees C for at least 1 year. The latex reagent was stable for at least 6 months at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523570      PMCID: PMC85719     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

2.  Blood culture techniques for the diagnosis of melioidosis.

Authors:  V Wuthiekanun; D Dance; W Chaowagul; Y Suputtamongkol; Y Wattanagoon; N White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

3.  Prognostic significance of quantitative bacteremia in septicemic melioidosis.

Authors:  A L Walsh; M D Smith; V Wuthiekanun; Y Suputtamongkol; W Chaowagul; D A Dance; B Angus; N J White
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

Review 4.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Production of specific monoclonal antibodies to Burkholderia pseudomallei and their diagnostic application.

Authors:  S Pongsunk; P Ekpo; T Dharakul
Journal:  Asian Pac J Allergy Immunol       Date:  1996-06       Impact factor: 2.310

6.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

7.  Evaluation of the API 20E and Microbact 24E systems for the identification of Pseudomonas pseudomallei.

Authors:  A D Thomas
Journal:  Vet Microbiol       Date:  1983-11       Impact factor: 3.293

8.  Isolation and characterization of the outer-membrane proteins of Burkholderia (Pseudomonas) pseudomallei.

Authors:  N Gotoh; N J White; W Chaowagul; D E Woods
Journal:  Microbiology       Date:  1994-04       Impact factor: 2.777

9.  Monoclonal antibodies to Pseudomonas pseudomallei and their potential for diagnosis of melioidosis.

Authors:  P Rugdech; N Anuntagool; S Sirisinha
Journal:  Am J Trop Med Hyg       Date:  1995-03       Impact factor: 2.345

10.  Detection of Pseudomonas pseudomallei antigen in urine for the diagnosis of melioidosis.

Authors:  V Desakorn; M D Smith; V Wuthiekanun; D A Dance; H Aucken; P Suntharasamai; A Rajchanuwong; N J White
Journal:  Am J Trop Med Hyg       Date:  1994-11       Impact factor: 2.345

View more
  10 in total

1.  Use of protein-specific monoclonal antibody-based latex agglutination for rapid diagnosis of Burkholderia pseudomallei infection in patients with community-acquired septicemia.

Authors:  Pattama Ekpo; Utane Rungpanich; Supinya Pongsunk; Pimjai Naigowit; Vimon Petkanchanapong
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Development of a diagnostic system for Burkholderia pseudomallei infections.

Authors:  P Trivedi; U Tuteja; R Khushiramani; Jain Reena; H V Batra
Journal:  World J Microbiol Biotechnol       Date:  2012-05-23       Impact factor: 3.312

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay.

Authors:  Gemma Robertson; Alanna Sorenson; Brenda Govan; Natkunam Ketheesan; Raymond Houghton; Hongjing Chen; David AuCoin; Michael Dillon; Robert Norton
Journal:  J Med Microbiol       Date:  2015-06-07       Impact factor: 2.472

6.  Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Adam Merritt; Glenys Chidlow; Max Aravena-Roman; Gerry Harnett
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test.

Authors:  Premjit Amornchai; Wirongrong Chierakul; Vanaporn Wuthiekanun; Yuvadee Mahakhunkijcharoen; Rattanaphone Phetsouvanh; Bart J Currie; Paul N Newton; Nguyen van Vinh Chau; Surasakdi Wongratanacheewin; Nicholas P J Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

8.  Rapid Clinical Screening of Burkholderia pseudomallei Colonies by a Bacteriophage Tail Fiber-Based Latex Agglutination Assay.

Authors:  Veerachat Muangsombut; Patoo Withatanung; Narisara Chantratita; Sorujsiri Chareonsudjai; Jiali Lim; Edouard E Galyov; Orawan Ottiwet; Sineenart Sengyee; Sujintana Janesomboon; Martin J Loessner; Matthew Dunne; Sunee Korbsrisate
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

9.  Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents burkholderia mallei and burkholderia pseudomallei.

Authors:  Jacob Gilad; David Schwartz; Yoram Amsalem
Journal:  Int J Biomed Sci       Date:  2007-09

10.  An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens.

Authors:  Jeslin J L Tan; Monica Capozzoli; Mitsuharu Sato; Wanitda Watthanaworawit; Clare L Ling; Marjorie Mauduit; Benoît Malleret; Anne-Charlotte Grüner; Rosemary Tan; François H Nosten; Georges Snounou; Laurent Rénia; Lisa F P Ng
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.